Annual report [Section 13 and 15(d), not S-K Item 405]

Summary of Significant Accounting Policies (Tables)

v3.26.1
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Schedule of Anti-dilutive Securities Excluded From Computation of Earnings Per Share The following securities were not included diluted shares outstanding because the effect would be anti-dilutive.

 

 

Years Ended December 31,

 

 

2025

 

 

2024

 

Stock options

 

 

4,664,742

 

 

 

5,287,284

 

Warrants

 

 

1,000,000

 

 

 

4,625,000

 

Convertible notes

 

 

307,701,076

 

 

 

176,222,145

 

Total anti-dilutive instrument

 

 

313,365,818

 

 

 

186,134,429